Summary
- Medical records from a single tertiary-care center were analyzed retrospectively for patients with hepatocellular carcinoma (HCC) who underwent selective transarterial chemoembolization (TACE).
- Patients had to meet specific criteria including age, tumor size, and absence of certain conditions to be included in the study.
- The TACE procedure involved catheterization of hepatic arteries, administration of a mixture of oil and chemotherapy drugs, and embolization of feeding arteries with gelatin sponge particles.
- Cone-beam CT imaging was used during the procedure to assess the distribution of Lipiodol, a contrast agent, and to ensure successful embolization of tumor-feeding branches.
- Analysis of tumor characteristics, treatment factors, and Lipiodol accumulation patterns revealed significant prognostic factors for patient outcomes, including local tumor recurrence, progression-free survival, and overall survival.
A team of medical experts recently carried out a study at a hospital to analyze how a specific treatment called transarterial chemoembolization (TACE) works for patients with liver cancer. The study looked at medical records of patients who received this treatment between 2015 and 2020. They only included patients who met certain criteria, like having small tumors and not receiving other treatments before TACE.
During the TACE procedure, the doctors inject a mixture of medicine and oil into the blood vessels that supply the tumor in the liver. This helps to kill the cancer cells. They also use tiny particles to block the blood flow to the tumor. After the procedure, they use a special type of imaging called cone-beam CT to make sure the treatment was successful.
The researchers collected data on different aspects of the patients’ health, like their liver function, tumor characteristics, and how the treatment was done. They found that the pattern of oil accumulation in the tumor after treatment was important. A uniform and complete accumulation of oil in the tumor meant that the treatment was more likely to be successful. On the other hand, if there were gaps or very little oil in the tumor, it might indicate that the treatment did not work as well.
The study also looked at the long-term outcomes of the treatment, like whether the cancer came back in the same place, spread to other parts of the liver, or caused complications. They found that the way the oil accumulated in the tumor could be a good indicator of how well the treatment would work in the long run.
Overall, the study showed that paying attention to how the oil spreads in the tumor after TACE can help doctors predict how successful the treatment will be for patients with liver cancer. By understanding these patterns, they can tailor the treatment to each individual patient to achieve the best possible outcome.
Source link
Oncology,Oncology,Radiology